Please Wait.....
Report
Global CRISPR Technology Market Report and Forecast 2023-2031
Market Report I 2023-04-12 I 147 Pages I EMR Inc.
Global CRISPR Technology Market Report and Forecast 2023-2031
Global CRISPR Technology Market Outlook
The CRISPR technology market size attained a value of USD 1.8 billion in 2022. By 2031, The market is likely to grow at a rate of 23.1% during the forecast period of 2023-2031 to attain a value of USD 11.9 billion by 2031. The growth can be attributed to the increase in the mergers and acquisitions of strategic key players.
CRISPR Technology Market: Introduction
The global CRISPR technology market is a rapidly growing market driven by the increasing demand for efficient and precise gene editing tools, the growing funding for genomics research, and advancements in CRISPR technology. The market refers to the market for the clustered regularly interspaced short palindromic repeats (CRISPR) technology, which is a revolutionary gene editing tool used to alter the DNA sequence of an organism. The market is being propelled by factors such as the increasing prevalence of genetic disorders, the rise in the geriatric population, and the growth of the biotechnology and pharmaceutical industries.
CRISPR Technology Market- Application and Usage
CRISPR technology has a wide range of applications and usage in various fields, including:
1. Gene therapy: CRISPR technology is used to treat genetic diseases by correcting or replacing the defective genes in a patient's cells. This approach has shown promising results in treating diseases such as sickle cell anaemia and cystic fibrosis.
2. Genetic engineering: CRISPR technology is used to modify the genes of plants and animals to enhance their characteristics, such as increased yield or disease resistance.
3. Drug discovery: CRISPR technology is used to identify new drug targets and test the effectiveness of potential drugs.
4. Agricultural biotechnology: CRISPR technology is used to develop crops that are resistant to pests and diseases, have a longer shelf life, and have better nutritional value.
5. Cancer research: CRISPR technology is used to study the genes that play a role in the development and progression of cancer, which could lead to the development of new cancer treatments.
6. Infectious disease research: CRISPR technology is used to study the genes of pathogens and develop new treatments for infectious diseases.
Overall, CRISPR technology has the potential to revolutionize many fields, from medicine to agriculture, by providing a precise and efficient tool for gene editing and modification.
CRISPR Technology Market Segmentations
The market can be categorised into type, Cas type, application, and end user.
Market Breakup by Type
- Cas9 and gRNA
- Design Tools
- Plasmid and Vectors
- Other Delivery System Products
Market Breakup by Cas Type
- Cas3 in Type I Systems
- Cas9 in Type II Systems
- Cas10 in Type III Systems
Market Breakup by Application
- Genome Engineering
- Disease Models
- Functional Genomics
- Knockdown/Activation
- Others
Market Breakup by End User
- Academic Research Organizations
- Biopharmaceutical Companies
- Agriculture Biotechnology Companies
- Contract Research Organizations (CROs)
CRISPR Technology Market Breakup by Region
- North America
? United States of America
? Canada
- Europe
? United Kingdom
? Germany
? France
? Italy
? Others
- Asia Pacific
? China
? Japan
? India
? ASEAN
? Australia
? Others
- Latin America
? Brazil
? Argentina
? Mexico
? Others
- Middle East and Africa
? Saudi Arabia
? United Arab Emirates
? Nigeria
? South Africa
? Others
CRISPR Technology Market Scenario
The global CRISPR technology market is expected to witness significant growth in the coming years. The market is being propelled by factors such as the increasing demand for efficient and precise gene editing tools, the growing funding for genomics research, and advancements in CRISPR technology. Moreover, the rise in the geriatric population, the increasing prevalence of genetic disorders, and the growth of the biotechnology and pharmaceutical industries are also driving the growth of the market.
North America is the dominant market for CRISPR technology, followed by Europe and the Asia Pacific. The high prevalence of genetic disorders, the presence of key players in the region, and the growing funding for genomics research are driving the growth of the market in North America and Europe. The Asia Pacific region is expected to witness the highest CAGR during the forecast period, owing to the growing demand for personalized medicine, the increasing prevalence of genetic disorders, and the rising healthcare expenditure in the region. Moreover, the growing investments in research and development activities and the presence of a large patient pool are expected to fuel the growth of the CRISPR technology market in the Asia Pacific region.
The CRISPR technology market is expected to face challenges such as ethical concerns surrounding gene editing and the high cost of CRISPR technology. However, the market is expected to present numerous growth opportunities such as the increasing demand for personalized medicine, the rising investments in research and development activities, and the growing adoption of CRISPR technology in developing countries.
Key Players in the Global CRISPR Technology Market
The report gives an in-depth analysis of the key players involved in the CRISPR Technology market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
- Horizon Discovery Group plc
- Sangamo Therapeutics
- GenScript Biotech
- Integrated DNA Technologies, Inc.
- Precision Biosciences
- Beam Therapeutics Inc.
- Thermo Fisher Scientific Inc.
- Intellia Therapeutics
- CRISPR Therapeutics AG
- Vertex Pharmaceuticals Incorporated
- New England Biolabs
- Agilent Technologies, Inc.
- Merck KGaA
1 Preface
1.1 Objectives of the Study
1.1.1 Research Objectives
1.1.2 Key Findings of the Report
1.2 Limitations of the Study and Scope for Future Research
2 Research Methodology
3 Executive Summary
4 Global CRISPR Technology Market
4.1 Global CRISPR Technology Market Overview
4.2 Global CRISPR Technology Market Analysis
4.2.1 Market Overview
4.2.1.1 Global CRISPR Technology Market Historical Value (2016-2022)
4.2.1.2 Global CRISPR Technology Market Forecast Value (2023-2031)
4.3 Global CRISPR Technology Market by Type
4.3.1 Market Overview
4.3.1.1 Cas9 and gRNA
4.3.1.2 Design Tools
4.3.1.3 Plasmid and Vectors
4.3.1.4 Other Delivery System Products
4.4 Global CRISPR Technology Market by Cas Type
4.4.1 Market Overview
4.4.1.1 Cas3 in Type I Systems
4.4.1.2 Cas9 in Type II Systems
4.4.1.3 Cas10 in Type III Systems
4.5 Global CRISPR Technology Market by Application
4.5.1 Market Overview
4.5.1.1 Genome Engineering
4.5.1.2 Disease Models
4.5.1.3 Functional Genomics
4.5.1.4 Knockdown/Activation
4.5.1.5 Others
4.6 Global CRISPR Technology Market by End User
4.6.1 Market Overview
4.6.1.1 Academic Research Organisations
4.6.1.2 Biopharmaceutical Companies
4.6.1.3 Agriculture Biotechnology Companies
4.6.1.4 Contract Research Organisations (CROs)
4.7 Global CRISPR Technology Market by Region
4.7.1 Market Overview
4.7.1.1 North America
4.7.1.1.1 Historical Trend (2016-2022)
4.7.1.1.2 Forecast Trend (2023-2031)
4.7.1.2 Europe
4.7.1.2.1 Historical Trend (2016-2022)
4.7.1.2.2 Forecast Trend (2023-2031)
4.7.1.3 Asia Pacific
4.7.1.3.1 Historical Trend (2016-2022)
4.7.1.3.2 Forecast Trend (2023-2031)
4.7.1.4 Latin America
4.7.1.4.1 Historical Trend (2016-2022)
4.7.1.4.2 Forecast Trend (2023-2031)
4.7.1.5 Middle East and Africa
4.7.1.5.1 Historical Trend (2016-2022)
4.7.1.5.2 Forecast Trend (2023-2031)
5 North America CRISPR Technology Market
5.1 United States of America
5.1.1 Historical Trend (2016-2022)
5.1.2 Forecast Trend (2023-2031)
5.2 Canada
5.2.1 Historical Trend (2016-2022)
5.2.2 Forecast Trend (2023-2031)
6 Europe CRISPR Technology Market
6.1 United Kingdom
6.1.1 Historical Trend (2016-2022)
6.1.2 Forecast Trend (2023-2031)
6.2 Germany
6.2.1 Historical Trend (2016-2022)
6.2.2 Forecast Trend (2023-2031)
6.3 France
6.3.1 Historical Trend (2016-2022)
6.3.2 Forecast Trend (2023-2031)
6.4 Italy
6.4.1 Historical Trend (2016-2022)
6.4.2 Forecast Trend (2023-2031)
7 Asia Pacific CRISPR Technology Market
7.1 China
7.1.1 Historical Trend (2016-2022)
7.1.2 Forecast Trend (2023-2031)
7.2 Japan
7.2.1 Historical Trend (2016-2022)
7.2.2 Forecast Trend (2023-2031)
7.3 India
7.3.1 Historical Trend (2016-2022)
7.3.2 Forecast Trend (2023-2031)
7.4 ASEAN
7.4.1 Historical Trend (2016-2022)
7.4.2 Forecast Trend (2023-2031)
7.5 Australia
7.5.1 Historical Trend (2016-2022)
7.5.2 Forecast Trend (2023-2031)
8 Latin America CRISPR Technology Market
8.1 Brazil
8.1.1 Historical Trend (2016-2022)
8.1.2 Forecast Trend (2023-2031)
8.2 Argentina
8.2.1 Historical Trend (2016-2022)
8.2.2 Forecast Trend (2023-2031)
8.3 Mexico
8.3.1 Historical Trend (2016-2022)
8.3.2 Forecast Trend (2023-2031)
9 Middle East and Africa CRISPR Technology Market
9.1 Saudi Arabia
9.1.1 Historical Trend (2016-2022)
9.1.2 Forecast Trend (2023-2031)
9.2 United Arab Emirates
9.2.1 Historical Trend (2016-2022)
9.2.2 Forecast Trend (2023-2031)
9.3 Nigeria
9.3.1 Historical Trend (2016-2022)
9.3.2 Forecast Trend (2023-2031)
9.4 South Africa
9.4.1 Historical Trend (2016-2022)
9.4.2 Forecast Trend (2023-2031)
10 Trade Data Analysis by HS Code
10.1 Geneart CRISPR Nuclease Mrna- 38220090
10.2 Csq33 DNA Sequencing Unit- 90272000
11 Current Scenario Evaluation and Regulatory Framework
11.1 Emerging Therapies and Clinical Trials Synopsis
11.2 Patent Landscape
11.2.1 Patent Overview
11.2.1.1 Patent Status and Expiry
11.2.1.2 Timelines from Device Development to Commercial Launch
11.2.1.3 New Device Application
11.2.1.3.1 Documentation and Approval Process
11.3 Cost of Treatment
11.4 Regulatory Framework
11.4.1 Regulatory Overview
11.4.1.1 US FDA
11.4.1.2 EU EMA
11.4.1.3 INDIA CDSCO
11.4.1.4 JAPAN PMDA
11.4.1.5 Others
12 Global CRISPR Technology Market Dynamics
12.1 Market Drivers and Constraints
12.2 SWOT Analysis
12.3 Porter's Five Forces Model
12.4 Key Demand Indicators
12.5 Key Price Indicators
12.6 Industry Events, Initiatives, and Trends
12.7 Value Chain Analysis
13 Supplier Landscape
13.1 Horizon Discovery Group plc
13.1.1 Company Overview
13.1.2 Product Portfolio
13.1.3 Demographic Reach and Achievements
13.1.4 Mergers and Acquisitions
13.1.5 Certifications
13.2 Sangamo Therapeutics
13.2.1 Company Overview
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 GenScript Biotech
13.3.1 Company Overview
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 Integrated DNA Technologies, Inc.
13.4.1 Company Overview
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Precision Biosciences
13.5.1 Company Overview
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 Beam Therapeutics Inc.
13.6.1 Company Overview
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Thermo Fisher Scientific Inc.
13.7.1 Company Overview
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 Intellia Therapeutics
13.8.1 Company Overview
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 CRISPR Therapeutics AG
13.9.1 Company Overview
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Vertex Pharmaceuticals Incorporated
13.10.1 Company Overview
13.10.2 Product Portfolio
13.10.3 Demographic Reach and Achievements
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
13.11 New England Biolabs
13.11.1 Company Overview
13.11.2 Product Portfolio
13.11.3 Demographic Reach and Achievements
13.11.4 Mergers and Acquisitions
13.11.5 Certifications
13.12 Agilent Technologies, Inc.
13.12.1 Company Overview
13.12.2 Product Portfolio
13.12.3 Demographic Reach and Achievements
13.12.4 Mergers and Acquisitions
13.12.5 Certifications
13.13 Merck KGaA
13.13.1 Company Overview
13.13.2 Product Portfolio
13.13.3 Demographic Reach and Achievements
13.13.4 Mergers and Acquisitions
13.13.5 Certifications
14 Recommendations and Discussion
15 Pricing Models and Strategies (Additional Insight)
15.1 Cost Model
15.1.1 Manufacturing Cost Analysis
15.1.2 Procurement Cost Analysis
15.1.3 Clinical Trial Cost Factors
15.2 Pricing Strategies
15.2.1 Competitor Pricing Analysis
15.2.2 Key Assessment of Product Attributes
15.2.3 Pricing Benchmark
16 Global CRISPR Technology Devices Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security